tiprankstipranks
Trending News
More News >
Atyr Pharma Inc. (ATYR)
:ATYR
US Market

aTyr Pharma (ATYR) Income Statement

Compare
2,088 Followers

aTyr Pharma Income Statement

Last quarter (Q4 2024), aTyr Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, aTyr Pharma's net income was $-14.97M. See aTyr Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 235.00K$ 353.00K$ 10.39M$ 0.00$ 10.46M
Gross Profit
$ 235.00K$ -2.39M$ 8.69M$ -1.30M$ -6.84M
Operating Expenses
$ 68.15M$ 55.27M$ 55.09M$ 32.71M$ 25.10M
Depreciation and Amortization
$ 1.54M$ 2.74M$ 1.70M$ 1.30M$ 1.27M
EBITDA
$ -66.37M$ -52.18M$ -44.71M$ -32.47M$ -14.64M
Operating Income
$ -67.91M$ -54.92M$ -46.40M$ -34.02M$ -15.91M
Other Income/Expenses
$ 3.89M$ 4.52M$ 1.06M$ 238.00K$ -319.00K
Pretax Income
$ -64.02M$ -50.40M$ -45.34M$ -33.78M$ -16.23M
Net Income
$ -64.02M$ -50.39M$ -45.34M$ -33.77M$ -16.22M
Per Share Metrics
Basic EPS
$ -0.86$ -0.94$ -1.60$ -1.77$ -1.77
Diluted EPS
$ -0.86$ -0.94$ -1.60$ -1.77$ -1.77
Weighted Average Shares Outstanding
74.26M 53.61M 28.42M 19.08M 9.16M
Weighted Average Shares Outstanding (Diluted)
74.26M 53.61M 28.42M 19.08M 9.16M
Currency in USD

aTyr Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis